美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

JASPER THERAPEUTICS INC C/WTS 24/09/2026 (TO PUR COM)

0.1250

-0.0150-10.71%

成交量：10.59万

成交额：1.33万

市值：156.25万

市盈率：- -

高：0.1399

开：0.1399

低：0.1250

收：0.1400

52周最高：0.2300

52周最低：0.0375

股本：1,250.00万

流通股本：- -

量比：6.60

换手率：- -

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

JASPER THERAPEUTICS INC C/WTS 24/09/2026 (TO PUR COM)

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.jaspertherapeutics.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Jasper Therapeutics, Inc.于2019年8月13日在特拉华州成立。该公司是一家临床阶段的生物技术公司，致力于通过针对肥大和造血干细胞的疗法实现治疗。该公司专注于开发和商业化更安全、更有效的治疗药物，用于治疗慢性自发性荨麻疹、低至中度风险骨髓增生异常综合征等疾病，以及干细胞移植和离体基因治疗的新型调理方案，这是一种在移植前在体外对细胞进行基因操作的技术。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/JSPRW/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"JSPRW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JSPRW\",,,,,undefined,":{"symbol":"JSPRW","market":"US","secType":"STK","nameCN":"JASPER THERAPEUTICS INC C/WTS 24/09/2026 (TO PUR COM)","latestPrice":0.125,"timestamp":1764968400000,"preClose":0.14,"halted":0,"volume":105876,"delay":0,"floatShares":0,"shares":12500000,"eps":0,"marketStatus":"休市中","change":-0.015,"latestTime":"12-05 16:00:00 EST","open":0.1399,"high":0.1399,"low":0.125,"amount":13274.2624,"amplitude":0.106429,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.14,"volumeRatio":6.599349277458673},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JSPRW\",,,,,undefined,":{"symbol":"JSPRW","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":6.599349277458673,"shares":12500000,"dividePrice":0,"high":0.1399,"amplitude":0.106429,"preClose":0.14,"low":0.125,"week52Low":0.0375,"pbRate":"--","week52High":0.23,"institutionHeld":0,"latestPrice":0.125,"eps":0,"divideRate":0,"volume":105876,"delay":0,"ttmEps":0,"open":0.1399,"prevYearClose":0.2096,"prevWeekClose":0.1368,"prevMonthClose":0.1368,"prevQuarterClose":0.0797,"fiveDayClose":0.1368,"twentyDayClose":0.13,"sixtyDayClose":0.0628},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JSPRW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JSPRW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JSPRW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.jaspertherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0863},{"period":"1month","weight":0.0611},{"period":"3month","weight":0.9142},{"period":"6month","weight":0.2488},{"period":"1year","weight":-0.3926},{"period":"ytd","weight":-0.4036}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Jasper Therapeutics, Inc.于2019年8月13日在特拉华州成立。该公司是一家临床阶段的生物技术公司，致力于通过针对肥大和造血干细胞的疗法实现治疗。该公司专注于开发和商业化更安全、更有效的治疗药物，用于治疗慢性自发性荨麻疹、低至中度风险骨髓增生异常综合征等疾病，以及干细胞移植和离体基因治疗的新型调理方案，这是一种在移植前在体外对细胞进行基因操作的技术。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.683316},{"month":2,"riseRate":0.5,"avgChangeRate":0.085616},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.108025},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.144526},{"month":5,"riseRate":0.666667,"avgChangeRate":0.074401},{"month":6,"riseRate":0.833333,"avgChangeRate":0.070897},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.112616},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.061335},{"month":9,"riseRate":0.5,"avgChangeRate":0.039126},{"month":10,"riseRate":0.333333,"avgChangeRate":0.171145},{"month":11,"riseRate":0.5,"avgChangeRate":0.033751},{"month":12,"riseRate":0.666667,"avgChangeRate":0.008144}],"exchange":"NASDAQ","name":"JASPER THERAPEUTICS INC C/WTS 24/09/2026 (TO PUR COM)","nameEN":"JASPER THERAPEUTICS INC C/WTS 24/09/2026 (TO PUR COM)"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"JSPRW\",market:\"US\",,,undefined,":null}}